Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

Relmada Therapeutics Q2 Earnings Call Highlights
Relmada Therapeutics Q2 Earnings Call Highlights

Key Points

Does Patterson-UTI (PTEN) Have the Potential to Rally 37.91% as Wall Street Analysts Expect?
Does Patterson-UTI (PTEN) Have the Potential to Rally 37.91% as Wall Street Analysts Expect?

Patterson-UTI (PTEN) closed the last trading session at $10.05, gaining 6.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts See a 34.93% Upside in Trimble (TRMB): Can the Stock Really Move This High?
Wall Street Analysts See a 34.93% Upside in Trimble (TRMB): Can the Stock Really Move This High?

Trimble Navigation (TRMB) closed the last trading session at $58.55, gaining 11.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

How Much Upside is Left in Gibraltar Industries (ROCK)? Wall Street Analysts Think 33.12%
How Much Upside is Left in Gibraltar Industries (ROCK)? Wall Street Analysts Think 33.12%

Gibraltar Industries (ROCK) closed the last trading session at $50.78, gaining 20.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Does Iovance Biotherapeutics (IOVA) Have the Potential to Rally 28.02% as Wall Street Analysts Expect?
Does Iovance Biotherapeutics (IOVA) Have the Potential to Rally 28.02% as Wall Street Analysts Expect?

Iovance Biotherapeutics (IOVA) closed the last trading session at $6.21, gaining 42.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

APA Q2 Earnings Call Highlights Cost Cuts and Permian EfficiencyPhoto, wide shot, wide-angle lens,  Coal company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.midjourneyapi.xyz/temp/2a011bdc-adca-4de9-8457-d868b31178cf.png
APA Q2 Earnings Call Highlights Cost Cuts and Permian Efficiency

APA Corporation APA used its second-quarter 2026 earnings call to emphasize lower capital intensity, higher U.S. oil output and a larger cost-savings target. CEO John Christmann and CFO Ben Rodgers

Saputo Earnings Rise as Dairy Giant Targets Protein Growth and Accretive DealsPhoto, wide shot, wide-angle lens,  Supermarket, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/12c4d93c-5c0e-4e39-8e32-e47404ce9d79.png
Saputo Earnings Rise as Dairy Giant Targets Protein Growth and Accretive Deals

Key Points

Devon Energy Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Gas company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://img.theapi.app/temp/01083d82-021d-4573-8c40-0e836a0771d6.png
Devon Energy Q2 Earnings Call Highlights

Key Points

FIGS Q2 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Data analytics provider, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/d1295d04-cceb-4f1c-be2b-32ca46621336.png
FIGS Q2 Earnings Call Highlights

FIGS (NYSE:FIGS) reported second-quarter fiscal 2026 revenue growth of 29% as demand increased across scrub wear, non-scrub apparel